n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cancer of Endometrium in 3 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"(4) NS-398 could restrain endometrial cancer cells invasion." | 1.35 | Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells. ( Jingting, C; Yi, Z; Yu, Z, 2009) |
"In human endometrial cancer, the fourth most common cancer in women, tumor suppressor phosphatase tensin homologue (PTEN) is frequently mutated." | 1.32 | Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. ( Asselin, E; Gagnon, V; Mathieu, I; Parent, S; St-Germain, ME, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yi, Z | 1 |
Jingting, C | 1 |
Yu, Z | 1 |
St-Germain, ME | 1 |
Gagnon, V | 1 |
Mathieu, I | 1 |
Parent, S | 1 |
Asselin, E | 1 |
Gao, J | 1 |
Niwa, K | 1 |
Takemura, M | 1 |
Sun, W | 1 |
Onogi, K | 1 |
Wu, Y | 1 |
Seishima, M | 1 |
Mori, H | 1 |
Tamaya, T | 1 |
3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cancer of Endometrium
Article | Year |
---|---|
Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Prol | 2009 |
Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
Topics: Apoptosis; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibito | 2004 |
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Topics: Blotting, Western; Butadienes; Cell Proliferation; Cyclooxygenase Inhibitors; Endometrial Neoplasms; | 2005 |